Drilldown: Medicines
Medicines > routes:
topical 
& onset :
Days or
IOP lowering at 4 hours, maximum at 8-12 hours; eyelash effect after 2 months
& onset :
Days or
IOP lowering at 4 hours, maximum at 8-12 hours; eyelash effect after 2 months Use the filters below to narrow your results.
generic:
classes:
mechanism:
None (1) ·
'"`UNIQ--vote-000009FD-QINU`"' Active against gram-positive cocci including MRSA; the unique target underlies the absence of cross-resistance with other antibiotic classes. High-level resistance (plasmid-mediated mupA) is rising and limits prolonged or repeated use'"`UNIQ--ref-000009FE-QINU`"'. (1)
uses:
starting dose:
Topical: 1% cream BID × 2-4 weeks; vaginal: 1% or 2% cream nightly × 7 days, or 100/200/500 mg vaginal tablet single or 3-day regimens; troche: 10 mg PO five times daily × 2 weeks for thrush (1) ·
Topical: apply small amount to affected area TID × 5-10 days; nasal: apply half the contents of a single-use tube into each nostril BID × 5 days (1)
preparations:
fda max:
routes: (Click arrow to add another value)
onset: (Click arrow to add another value)
duration:
halflife:
bioavailability:
pregnancy:
Generally considered safe; minimal systemic exposure.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Topical and vaginal generally considered safe; widely used.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
Showing below up to 2 results in range #1 to #2.